90% Public Hospital
Hong Kong Pharmaceutical Market is one of the smallest in Asia. However, it has unique opportunities thanks to its structure.
Hong Kong pharmaceutical Hospital Market is 90% Public and 10% Private.
10 % Private Hospital
Hospital Authority has been providing services to the public under a cluster-based structure. It currently manages 42 public hospitals and institutions, 48 specialist outpatient clinics and 73 general outpatient clinics. Queen Mary Hospital, Pamela Youde Nethersole Eastern Hospital, Hong Kong children hospitals are some of the most famous public hospitals in Hong Kong.
Beside there are 12 Private Hospitals in Hong Kong.
Public market supply is organized through central tenders that run for 3 years with winner-takes-all scheme. Winning this central tender will gives us 100% of the market share in Public Hospitals (which are equivalent to 90% of the Hospital Market). Private Sector relies mostly on originators/branded products for their supplies.
Benefits from this system
If the tender is awarded to us, then the supply is guaranteed for 3 years and you will get 100% of the market share of HK public hospitals at once.
You will not face any supply planning issues since quantities requested by Hospital Authority have underlying commitment.
Drawback
If we are not awarded, no sales could be made in Hong Kong for the next 3 years.
The best way to mitigate this risk is to launch and focus only on medicines that have very good chances to win the tender. As such one of the key assets of PHA is our ability to foresee and raise assumptions in the market directions. Thanks to our experiences and knowledge about the competition and the tender value history, we are able to choose the right products to commercialize and maximize our chances of winning the tender.
We start registration of a product only if we are confident in its potential to win the tender.
Please get in touch with us if you want to know more about the potential of your drug in Hong Kong.
TELEPHONE : +852 9160 5902
EMAIL : enquiries@pharmhealthcareasia.com
As for registration Hong Kong is very structured, the processes and required documents are well defined and consistent throughout the years. The total time for a registration varies between 9 to 15 months depending on the number of questions raised by Department of Health.
Our team is proficient in the registration of drugs in Hong Kong and will be able to guide you on how to compile the dossier to pass the evaluation. The comprehensive list of documents requested for a tender is available here.
Hong Kong has a few unique advantages versus the rest of Asia when it comes to registration:
A simplified dossier is sufficient.
Wide range of product stability conditions are accepted (including <25°C).
Review within 9 to 15 months; one of the fastest timeline in Asia Pacific.
Please get in touch with us if you want to know more about the likeliness of your dossier to comply with Hong Kong Standards.
About Macau
Macau is a small territory with an independent health authority. They rely mainly on China or Hong Kong for medical supplies. A product registered in Hong Kong will be allowed to be commercialized in Macau and attending tenders without applying for a local marketing authorization. There is 1 major Public Hospital (Hospital Conde S. Januário) and one major Private Hospital (Kiang Wu Hospital).
